Market revenue in 2022 | USD 93.3 million |
Market revenue in 2030 | USD 136.5 million |
Growth rate | 4.9% (CAGR from 2022 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Enzymes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Enzymes |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.2% in 2022. Horizon Databook has segmented the South Africa molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
In South Africa, microbiology laboratories are shifting toward the implementation of molecular biology techniques for the diagnosis of pathogens causing infectious diseases and identification of genotypic characterization of these organisms.
This is anticipated to contribute to revenue generation by increasing the use of molecular biology enzymes, kits, and reagents in the country. Moreover, in July 2018, the first high-throughput genomics sequencing center was launched in South Africa.
This was launched by the South African Medical Research Council (SAMRC). This center offered access to technologically advanced facilities, further increasing local capacity in sequencing technology. In addition, Human Whole Genome Sequencing project was conducted in South Africa. This study was published in June 2020.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This country databook contains high-level insights into South Africa molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account